ReviewInternational immunopharmacology2020
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.
Tania Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled itcites it